Karen Roessner
About
In The Last Decade
Karen Roessner
20 papers receiving 636 citations
Peers
Comparison fields: 5 of 74
- Immunology 298
- Infectious Diseases 189
- Epidemiology 109
- Genetics 94
- Molecular Biology 87
Countries citing papers authored by Karen Roessner
This map shows the geographic impact of Karen Roessner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Roessner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Roessner more than expected).
Fields of papers citing papers by Karen Roessner
This network shows the impact of papers produced by Karen Roessner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Roessner. The network helps show where Karen Roessner may publish in the future.
Co-authorship network of co-authors of Karen Roessner
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Roessner. A scholar is included among the top collaborators of Karen Roessner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Roessner. Karen Roessner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 36 | |
| 2 | 28 | |
| 3 | 11 | |
| 4 | Lyme arthritis synovial gamma delta T cells respond to Borrelia burgdorferi lipoproteins and lipidated hexapeptides. | 42 |
| 5 | 37 | |
| 6 | 90 | |
| 7 | 2 | |
| 8 | 26 | |
| 9 | 28 | |
| 10 | 44 | |
| 11 | Antibodies to denatured type II collagen in rheumatoid arthritis: negative association with IgM rheumatoid factor. | 9 |
| 12 | 2 | |
| 13 | 24 | |
| 14 | 19 | |
| 15 | 85 | |
| 16 | 10 | |
| 17 | 54 | |
| 18 | 7 | |
| 19 | 12 | |
| 20 | 107 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.